NCT06691542View on ClinicalTrials.gov

Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 30, 2025

Conditions
Non-Genital Warts
Interventions
DRUG

platelet-rich plasma

platelet-rich plasma, metformin and cryotherapy in treatment of non-genital warts

DRUG

Metformin

platelet-rich plasma, metformin and cryotherapy in treatment of non-genital warts

OTHER

cryotherapy

platelet-rich plasma, metformin and cryotherapy in treatment of non-genital warts

All Listed Sponsors
lead

Assiut University

OTHER

NCT06691542 - Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts | Biotech Hunter | Biotech Hunter